An Unusual Association Between Pancreatic Cancer and Purtscher-like Retinopathy
NCT05350384 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1
Last updated 2022-04-28
Summary
AN UNUSUAL ASSOCIATION BETWEEN PANCREATIC CANCER AND PURTSCHER-LIKE RETINOPATHY
Conditions
- Purtscher Retinopathy
- Pancreatic Cancer
Interventions
- DRUG
-
Methylprednisolone
1 g. of methylprednisolone in saline solution 250 cc once a day for 5 days, and one eye drops of Diclofenac per eye 3 times a day for 30 days
Sponsors & Collaborators
-
University of Catania
lead OTHER
Eligibility
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-06-18
- Primary Completion
- 2021-07-31
- Completion
- 2021-11-01
Countries
- Italy
Study Locations
More Related Trials
-
Genetic, Microenvironmental, and Immunological Factors in Unresectable Pancreatic Ductal Adenocarcinoma
NCT05248750 ·Status: RECRUITING
-
Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas
NCT00837031 ·Status: COMPLETED ·Phase: PHASE2
-
Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine
NCT00550004 ·Status: TERMINATED ·Phase: PHASE2
-
Mutation of K-RAS, CDKN2A, SMAD4 and TP53 in Pancreatic Cancer: Role of Liquid Biopsy in Preoperative Diagnosis
NCT03524677 ·Status: UNKNOWN
-
Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs
NCT02294006 ·Status: UNKNOWN ·Phase: PHASE2
-
Induction FOLFIRINOX Followed by Chemoradiation in Locally Advanced Pancreatic Cancer
NCT05399394 ·Status: UNKNOWN ·Phase: PHASE2
-
PROOF: Pancreatitis-associated Risk Of Organ Failure
NCT03075605 ·Status: COMPLETED
-
Radiofrequency Splanchnic Denervation Versus Retrocrural Neurolytic Celiac Block for Pancreatic Cancer Pain
NCT03886298 ·Status: UNKNOWN ·Phase: NA
-
Exocrine Pancreatic Insufficiency After Acute Pancreatitis and Pancreatic Enzyme Replacement Therapy
NCT05480241 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Interobserver Agreement on the Resectability Status of Patients With a Pancreatic Cancer
NCT03673423 ·Status: UNKNOWN
-
Span-C-SBRT for Pancreatic Cancer
NCT03505229 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Neoadjuvant Stereotactic Body Radiation Therapy for Resectable Adenocarcinoma of the Pancreatic Head and/or Body
NCT02208024 ·Status: COMPLETED ·Phase: NA
-
Study of Induction Chemotherapy Followed by Radiochemotherapy in Locally Advanced Pancreatic Cancer
NCT02984501 ·Status: COMPLETED ·Phase: PHASE2
-
SARcopenia in Patients With ChrOnic PANcreatitis: the SARCOPAN Study
NCT06092307 ·Status: UNKNOWN ·Phase: NA
-
Diagnosis and Survival Prediction of Pancreatic Cancer by Machine Learning of Image Data
NCT05313854 ·Status: UNKNOWN
-
Pilot Study of Short-Course Preoperative Stereotactic Body Radiation Therapy for Resectable Pancreatic Cancer
NCT02347618 ·Status: COMPLETED ·Phase: NA
-
The Evaluation of Pro/Antioxidative Profile and Diagnostic Parameters in the Patients With Pancreatic Disease
NCT03028181 ·Status: COMPLETED
-
tailOred dRug repurposIng of dEcitabine in KRAS-dependeNt refracTory pAncreaTic cancEr
NCT05360264 ·Status: TERMINATED ·Phase: PHASE2
-
Nivolumab and All-trans Retinoic Acid for Pancreatic Cancer
NCT05482451 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
Pilot Study of Pancreatic Cancer Screening
NCT05058846 ·Status: RECRUITING
-
Clinician Decision Making Regarding Surveillance for Low-risk Intraductal Papillary Mucinous Neoplasms of The Pancreas
NCT06311032 ·Status: COMPLETED
-
Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
NCT02456051 ·Status: TERMINATED
-
PARA (Pancreatic Adenocarcinoma Etiology: Role of Asbestos) Study of Risk Factors for Exocrine Pancreatic Neoplasms.
NCT06815172 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Registry of Young-Adult Patients Diagnosed With Pancreatic Cancer
NCT05845801 ·Status: RECRUITING
-
Markers in Acute Pancreatitis-1
NCT05279079 ·Status: COMPLETED